Rifampicin is a first-line antituberculosis drug. More and more strains of tuberculosis are becoming resistant to this compound but it should still be used in the initial fight.
Rifampicin is a first-line antituberculosis drug. More and more strains of tuberculosis are becoming resistant to this compound but it should still be used in the initial fight.